血液病學專委會主委-許蘭平

　　許蘭平，北京大學人民醫院，北京大學血液病研究所，主任醫師，教授，博士生生導師，副主任。

　　一直從事血液系統疾病的診治和造血干細胞移植工作，在供者選擇、移植合并癥處理，尤其在移植治療再生障礙性貧血和重癥感染方面積累了豐富的經驗。承擔國自然項目2項、曾參加國家科技支撐項目和重大新藥創制科技重大專項子課題，發表SCI論文30余篇，參與發表論文SCI或核心期刊文章近300篇。2014和2017年兩次名列國家科技進步二等獎獲獎人員名單。曾任中華醫學會第七、八、九屆血液學分會造血干細胞應用學組成員兼秘書，現任海峽兩岸醫藥衛生交流協會第三屆理事會常務理事及第二屆血液學專委會主任委員，中國研究型醫院學會細胞研究與治療專委會常務委員，中國醫師協會血液學分會常務委員、中國造血干細胞捐獻者資料庫第八屆專家委員會委員、北京造血干細胞資料供者庫專家，《白血病.淋巴瘤》《中華老年多器官雜志》雜志編委,《中華血液學雜志》通訊編委，《中華內科雜志》審稿人。

　　近三年發表SCI文章：

　　1.Xu LP, Xu ZL, Wang FR, Mo XD, Han TT, Han W, Chen YH, Zhang YY, Wang JZ, Wang Y, Yan CH, Sun YQ, Tang FF, Zhang XH, Huang XJ.

　　Unmanipulated haploidentical transplantation conditioning with busulfan, cyclophosphamide and anti-thymoglobulin for adult severe aplastic anaemia.

　　Bone Marrow Transplant. 2018 Feb;53(2):188-192. doi: 10.1038/bmt.2017.237. Epub 2018 Jan 15

　　2.Xu L, Chen H, Chen J, Han M, Huang H, Lai Y, Liu D, Liu Q, Liu T, Jiang M, Ren H, Song Y, Sun Z, Wang J, Wu D, Zhou D, Zou P, Liu K, Huang X.

　　The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology.J HematolOncol. 2018 Mar 2;11(1):33. doi: 10.1186/s13045-018-0564-x. Review

　　 3.Cheng Y¹, Xu Z¹, Zhang Y¹, Wu J², Wang F¹, Mo X¹, Chen Y¹, Han W¹, Jia J¹, Wang Y¹, Zhang X¹, Huang X^1,3, Zhang L², Xu L¹

　　First-line choice for severe aplastic anemia in children: Transplantation from a haploidentical donor vs immunosuppressive therapy.clinical transplantation  2018 Feb;32(2). doi: 10.1111/ctr.13179. Epub 2018 Jan 3.

　　4、Xu LP, Jin S, Wang SQ, Xia LH, Bai H, Gao SJ, Liu QF, Wang JM, Wang X, Jiang M, Zhang X, Wu DP, Huang XJ.Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant.J HematolOncol. 2017 Jan 21;10(1):25.

　　5、Xu LP, Zhang XH, Wang FR, Mo XD, Han TT, Han W, Chen YH, Zhang YY,  Yan CH, Sun YQ, Zuo SN, Huang XJ.Haploidentical transplantation for pediatric patients with acquired severe aplastic anemia.Bone Marrow Transplant. 2017 Mar;52(3):381-387.

　　6、Xu LP, Wu DP, Han MZ, Huang H, Liu QF, Liu DH, Sun ZM, Xia LH, Chen J, Wang HX, Wang C, Li CF, Lai YR, Wang JM, Zhou DB, Chen H, Song YP, Liu T, Liu KY, Huang XJ.

　　A review of hematopoietic cell transplantation in China: data and trends during 2008-2016.Bone Marrow Transplant. 2017 Nov;52(11):1512-1518.

　　7、Chen Y, Huang XJ, Liu KY, Chen H, Chen YH, Zhang XH, Wang Y, Wang FR, Han W, Wang JZ, Yan CH, Xu LP.Association between C-reactive protein levels in the first 1-3 days post-transplant and allogeneic immune reactions.Biomark Med. 2017 Feb;11(2):117-124.

　　8、Xu LP, Wang SQ, Wu DP, Wang JM, Gao SJ, Jiang M, Wang CB, Zhang X, Liu QF, Xia LH, Wang X,Huang XJ. Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study.

　　Br J Haematol. 2016 Oct;175(2):265-274. doi: 10.1111/bjh.14225.

　　9、Ma YR, Huang XJ, Xu ZL, Liu KY, Chen H, Zhang XH, Han W, Chen YH, Wang FR, Wang JZ, Wang Y, Chen Y, Yan CH, Xu LP. Transplantation from haploidentical donor is not inferior to that from identical sibling donor for patients with chronic myeloid leukemia in blast crisis or chronic phase from blast crisis.Clin Transplant. 2016 Sep;30(9):994-1001. doi: 10.1111/ctr.12779

　　10、Tang FF, Huang XJ, Zhang XH, Chen H, Chen YH, Han W, Chen Y, Wang FR, Wang Y, Wang JZ, Yan CH, Sun YQ, Mo XD, Liu KY, Xu LP.

　　Allogeneic hematopoietic cell transplantation for adult patients with treatment-related acute myeloid leukemia during first remission: Comparable to de novo acute myeloid leukemia.Leuk Res. 2016 Aug;47:8-15. doi: 10.1016/j.leukres.2016.05.005

　　11、Xu ZL, Huang XJ, Liu KY, Chen H, Zhang XH, Han W, Chen YH, Wang FR, Wang JZ, Wang Y, Chen Y, Yan CH, Xu LP.

　　Haploidentical hematopoietic stem cell transplantation for paediatric high-risk T-cell acute lymphoblastic leukaemia.Pediatr Transplant. 2016 Jun;20(4):572-80. doi: 10.1111/petr.12704.

　　12、Xu LP, Xu ZL, Zhang XH, Chen H, Chen YH, Han W, Chen Y, Wang FR, Wang JZ, Wang Y, Yan CH, Mo XD, Liu KY, Huang XJ.

　　Allogeneic Stem Cell Transplantation for Patients with T315I BCR-ABL Mutated Chronic Myeloid Leukemia.Biol Blood Marrow Transplant. 2016 Jun;22(6):1080-6. doi: 10.1016/j.bbmt.2016.03.0126